We undertook a prospective longitudinal study of thyroid function in 36 pregnant women. There were significant increases in thyroxin-binding globulin, thyrotropin, and triiodothyronine. Albumin, free thyroxin (measured by an analog and a nonanalog method), and the free thyroxin index were significantly decreased. Results for the free thyroxin methods were correlated with each other in each trimester. We could find no evidence for artifacts related to albumin or thyroxinbinding globulin with either method for free thyroxin.
Increasedconcentrations
of thyroxm (T4), triiodothyronine (T3), and thyroxin-binding globulin (TBG) have been widely described in pregnancy, invariably in association with a subnormal concentration of albumin in serum (1) . ' The thyroliberin testiscontraindicated in pregnancy and, until methods for thyrotropin (TSH) having lower detection limits and greater specificity were introduced (2), temporal changes from basal TSH concentrations were difficult to study. No prospective longitudinal studies in which these improved TSH methods were used have been reported regarding such changes during pregnancy nor any examination of such changes in relation to other biochemical indicatore of thyroid function.
Methods for measuring unbound thyroid hormones give results that are controversial. Free T4 (FF) has been variously reported as increasing, decreasing, or not changing during pregnancy (3); as measured by analog assays, however, a decrease in VP.4 has been almost universally reported. Such findings have been met with claims that currentanalog methods are influenced by changes in the concentrations of albumin, TBG, and nonesterifled fatty acids (4) and that the changes in FL1 found with analog methods during pregnancy are related to changes in these analytes (5).
We undertook a prospective study of thyroid function in pregnancy, comparing a non-analog-based assay of VP4, the results of which correlate very well with those by equilibrium dialysis in pregnancy samples (6, 7), with a new formulation of an analog-based FF4 method (8).
U.K. TBG reagents
were obtained from Behring Diagnostics, Hounslow, Middlesex, U.K. The non-analog VP4 method was supplied by Mallinckrodt (UK), Round Spinney, Northampton, U.K. TSH was estimated by an immunoradiometric method with reagents produced by North East Thames Region Iminunoassay Unit, St. Bartholomew's Hospital, London, U.K.; the lower limit of detection of this method is 0.08 milli-int. unitlL. Albumin was measured by the bromcresol green dye-binding method with an RA-1000 discrete analyzer (Technicon Instruments Corp., Basingstoke, Hampshire, U.K.). Manufacturers' instructions were followed for all analyses. The between-batch coefficient of variation for all analytes was <10% for the concentration ranges reported.
Informed consent was obtained from 36 pregnant women and bloodsamples were taken during each trimester. The sampling times for each trimester were: first trimester, 10-13 weeks, median 12; secondtrimester, 15-18 weeks, median 16; and third trimester, 26-38 weeks, median 32. All women were clinically euthyroid and had no previous known thyroid disorders. Serum samples were separated within 2 h, frozen immediately, and stored at -20 #{176}C until analyzed.
Student's paired t-test was used to test for intra-individual changes. Spearman's ranking correlation method and Thiel's incomplete regression method were also used (9).
Results
The results for all analytes are displayed in Figure 1 , and the statistical significance of any changes is shown in Table  1 . During the period of study, there was no significant change in T4 concentration, but FF1, and T3 and TSH concentrations, showed an upward trend that became signif. icant during the third trimester. Throughout the period of study there was a significant decrease, by both methods, in Fr4 and in albumin concentrations; in contrast, TBG concentration was significantly increased.
Relationship of changes in FT4 with albumin and TBG. For boththe analog(DVF4)and non-analog (MVF4) methods there were no significant correlations between results for FF4 and the concentrations of TBG or albumin, or between changes in VP4 and changes in TBG between trimesters. The decline in Fr4 and albumin concentrations was not significantly correlated between the first and third, or second and third trimesters; however, there was a significant correlation (P <0.05) between results obtained in the first and secondtrimesters (Figure2).
Comparison of the MFT4 and the DFT4 assays. Results by these two methods were significantly correlated (P <0.01) in each trimester (Figure 3) . The slopes of the regression lines for each trimester were not significantly different from unity or from each other, indicating there was no doserelated bias between the methods. However, the y-axis intercepts were significantly different (P <0.01) from each other and from zeroin each trimester. If the y-axisintercepts had been constant for each trimester, then the bias between the two methods could be explained by differences in standardization. 
However, the bias between the two
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2nd-3rd lst-3rd This trimester-related bias may therefore be related to changes in the serum matrix duringpregnancy.
Discussion
The basis of a valid, theoretically sound, free hormone assay involving a radiolabeled analog T4 molecule is that the analog is totally unreactive with serum. Early commercial analog assays did not conform with this criterion; consequently, misleading results were produced in late pregnancy and in other conditions-e.g., nonthyroidal illness, familial dysalbuminemic hyperthyroxinemia, analbuminemia, the presence of antibodies to T4, and heparin therapy. Artifacts revealed by the addition of albumin to serum have recently been shown to be dependent on the type of purified albumin used (10). It is therefore essential to use endogenous albumin to assess the effect of albumin on analog Fr4 assays.
The natural physiological decrease in the albumin concentration in serum during pregnancy allows the intraindividual variations in FF4 values to be measured against changes in albumin concentration. Hence the presence of albumin-related artifacts may be assessed. Because TBG concentrations increase during pregnancy, the same study can be used to assess any TBG-related changes in Fl'4 concentration.
TBG and thyroxin-binding prealbuinin lack affinity for the analogused in the DFF4 assay, and binding to albumin is prevented by blocking agents in thatmethod (11). Previous reports of increased Fr4 concentrations in euthyroid patients with increased TBG concentrations (4,12,13) have been ascribed to the binding of excess albumin blocker to TBG, thereby displacing T4 (11). The blocker concentration can be optimized to eliminate analog binding to albumin while minimizing T4 displacement from TBG (8). We therefore compared the DFF4 assay with the MVF,4 assay, the latter having been shown to correlate very well with equilibrium dialysis in most clinical situations, including pregnancy (6) .
Sensitivity to changes in albumin concentration by analog methods has been used to explain the decrease in Fl'4 observed as a pregnancy progresses (5). If the analogtracer binds to albumin, the concentration of unbound analog tracer must be maintained by increasing its total concentration. Satisfactory results are obtained so long as the number of albumin-binding sites for the analog tracer remains Alterations in the concentrations of Fr4 (measured by both methods) and of albumin between the first and second trimesters were correlated. However, because the MFF4 assay is not subject to albumin-related artifacts, the correlation observedis therefore not causal, either for this method or for the DFr4 assay, as shown by the regression equations obtained for the Fr4 assays being not significantly different (Figure 2) . Moreover, if the correlation were causal it would also have been observed between other trimesters. Both methods appear, therefore, to be insensitive to changes in albumin concentration. Neither Fr4 method appeared to be affected by changes in TBG concentration, because there were no significant correlations between Fl'4 and TBG, or between changes in Fr4 and changes in TBG between trimesters.
Higher values are obtained with the DFr4 method than withthe MYF4 method, but this is reflected in the difference between the euthyroid reference ranges (Figure 1) . Two patients, one by each method, were below the lower limit of the reference range. However, this was not unexpected: one or two patients from a sample of 36 would be predicted to fall outside a reference range based on 95% confidence limits.
Thyroid hormones are carried in the blood bound to proteins (TBG, albumin, thyroxin-binding prealbumin). The unbound or "free" fraction is the physiologically active moiety (14) and regulates the production of TSH by feedback to the pituitary gland. TSH output is controlled by thyroliberm produced by the hypothalamus, which is under the control of higher brain centers (15, 16). T3 is known to be about 20 times more potent than T4. In euthyroid nonpregnant females, most of the T3 supplied to the body arises from peripheral conversion, by the liver and kidneys, ofT4 into T3: only -20% of the T3 is produced directly by the thyroid gland. T4 and T3 production by the thyroid is controlled by TSH. The pituitary gland, on the other hand, obtains most of itsT3 from internal conversion of 'F4, rather than from peripherally circulating T3.
The significant increase in TSH values during pregnancy may be occurring in response to the observed decrease in Fr4 concentrations; however, there were no correlations between intra-individual changes in Fr4 and TSH. The placenta is an additional site of conversion ofT4 to T3 (1), possibly accounting for the significant decrease (P <0.001) in the ratio of T4:T3 that occurs between the first and third trimesters.
The increase in T4 observed in the first trimester could be due to thyroid stimulation by human choriogonadotropin, the concentration of which peaks at 10-13 weeks of gestation, decreasing thereafter to a relatively stable value by 20 weeks of gestation (17) . This decline in human choriogonadotropin concentration may lead to a decrease in the Fl'4 concentration and to a subsequent increase in TSH output from the pituitary. However, the lack of correlation between changes in Fr4 and TSH concentrations may also be explained by poorly understood variations in the concentrations of thyroid hormone receptors in the pituitary, a phenomenon described in mononucleated leukocytes during pregnancy (17) .
The data presented here emphasize the need for a greater understanding of thyroid physiology during pregnancy. Further research is required if accurate predictions are to be made regarding changes in the concentrations of thyroid hormones in this group of patients. Such research should aim to confirm the presence and identity of non-TSH thyroid stimulators and to establish whether changes in receptor concentrations occur in cells other than mononucleated leukocytes.
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